Human clinical trials scheduled
Scientists may have overcome a major roadblock in the development of Alzheimer’s therapies by creating a new technology to observe ? in the back of the eye ? progression of the disease before the onset of symptoms. Clinical trials are to start in July to test the technology in humans according to a paper recently published in Investigative Ophthalmology & Visual Science (IOVS).
The paper, titled Early detection of amyloidopathy in Alzheimer’s mice by hyperspectral endoscopy, builds upon previous work in cells by detecting changes in the retina of mice predisposed to develop Alzheimer’s.
Early detection of Alzheimer’s is critical for two reasons. “First, effective treatments need to be administered well before patients show actual neurological signs,” said author Robert Vince, PhD, of the Center for Drug Design at the University of Minnesota (UMN). “Second, since there are no available early detection techniques, drugs currently cannot be tested to determine if they are effective against early Alzheimer’s disease. An early diagnostic tool like ours could help the development of drugs as well.”
Looking through the eye to see the brain is a key advantage of the new technology. “The retina of the eye is not just ‘connected’ to the brain — it is part of the central nervous system,” said author Swati More, PhD, also of the Center for Drug Design at UMN. While the brain and retina undergo similar changes due to Alzheimer’s disease, “unlike the brain, the retina is easily accessible to us, making changes in the retina easier to observe.”
“We saw changes in the retinas of Alzheimer’s mice before the typical age at which neurological signs are observed,” said More. “The results are close to our best-case scenario for outcomes of this project.”
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- The Many Ways of Coping With Alzheimer’son January 11, 2020 at 9:00 am
I am the neurologist with early-stage Alzheimer’s disease mentioned in “A Test for Alzheimer’s Poses a Tough Choice” (Science Times, Dec. 24). Testing for Alzheimer’s, especially in the earliest ...
- Signs of early-onset Alzheimer's: When not to worry, and when to see a doctoron January 10, 2020 at 2:22 pm
Are other troubling behavior symptoms appearing? People think Alzheimer’s is all about memory loss, Sperling says, but behavioral and personality changes — such as difficulty communicating, an ...
- One night of sleep loss may increase risk for Alzheimer's diseaseon January 10, 2020 at 9:42 am
No sleep for one night increased levels of the Alzheimer’s disease biomarker tau among young, healthy men, according to results of a two-condition crossover study published in Neurology. “Based on the ...
- To curb dementia including Alzheimer's, consider lifestyle changes and new metro-area classeson January 10, 2020 at 7:35 am
The program gives participants a good chance of truly making the sustainable changes that substantially reduces the risk of developing dementia.
- Alzheimer’s Drugs Market 2020-2026: Global Size, Share, Emerging Trends, Demand, Growth Analysis, Revenue and Forecasts Researchon January 9, 2020 at 11:59 pm
The Alzheimer's Drugs Market report is prepared on the bases of in-depth market analysis with inputs from key market players and industry experts. It covers several significant aspects, such as market ...
- Swastika Drawn on Toronto Alzheimer’s Patienton January 9, 2020 at 12:14 pm
Family members of a 65-year-old man with Alzheimer’s reportedly discovered a swastika drawn on the patient at a Toronto care facility. On January 8, Shane Morrow told Toronto.com, a local Toronto ...
- Kudos to Rep. Demings for Alzheimer’s attention | Letterson January 9, 2020 at 11:40 am
At the beginning of each new year there is hope. Hope for a year filled with new promises and new goals. This year, there is new hope in the fight against Alzheimer’s. Last month, President Trump ...
- Boise State Study Looks At Failing Alzheimer's Drugson January 9, 2020 at 9:21 am
In 2019, 26,000 Idahoans 65 and older were living with Alzheimer’s disease. Now, new research suggests that drugs being tested to stop that disease are not working. Some scientists say 30 years of ...
- One Night of Bad Sleep May Raise Alzheimer's Riskon January 9, 2020 at 7:22 am
WEDNESDAY, Jan. 8, 2020 (HealthDay News) -- Poor sleep has been linked to the development of dementia and Alzheimer's disease, and now a new study suggests a possible reason why. A small group of ...
- Just one bad night's sleep 'raises levels of an Alzheimer's biomarker by 17%'on January 9, 2020 at 7:12 am
Just one bad night’s sleep can raise levels of an Alzheimer’s biomarker in the blood, research suggests. Scientists from Uppsala University in Sweden deprived 15 healthy men of a decent night’s kip.
via Bing News